As Vice President at PhRMA, Kristen Bernie leverages her extensive experience as a health policy analyst to navigate the complex landscape of healthcare legislation. With 15 years of expertise, she is adept at developing legislative strategies that not only align with PhRMA's priorities but also...
As Vice President at PhRMA, Kristen Bernie leverages her extensive experience as a health policy analyst to navigate the complex landscape of healthcare legislation. With 15 years of expertise, she is adept at developing legislative strategies that not only align with PhRMA's priorities but also anticipate and mitigate potential congressional and administrative challenges. Kristen’s role is pivotal in fostering collaboration across various departments and member companies, ensuring that policy proposals are effectively socialized and supported.
One of her key projects involves conducting comprehensive federal budget and industry impact estimates for a range of legislative proposals. This analytical work is critical in understanding how new policies can affect government outlays and industry revenues, allowing PhRMA to advocate for policies that promote innovation while safeguarding the interests of its members. Kristen’s proficiency in quantitative analytics and data analysis enables her to model the potential impacts of legislation with precision, providing invaluable insights that inform strategic decision-making.
In addition to her analytical capabilities, Kristen is a skilled communicator, regularly engaging with member companies, alliance groups, and congressional staff. Her ability to translate complex economic data into actionable policy insights not only enhances PhRMA’s advocacy efforts but also strengthens relationships with key stakeholders. By combining her expertise in public policy and business strategy, Kristen Bernie plays a crucial role in shaping the future of healthcare policy, ensuring that the pharmaceutical industry can continue to thrive while delivering innovative solutions to patients.
